Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Curateq Biologics Private Limited, is an unlisted private company incorporated on 25 April, 2020. It is classified as a private limited company and is located in Rangareddi, Telangana. It's authorized share capital is INR 100.00 cr and the total paid-up capital is INR 100.00 cr.
Curateq Biologics's operating revenue range is Under INR 1 cr for the financial year ending on 31 March, 2023.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR lacs. Based on March 2023 numbers.
-100.0%
66.5%
21.69%
-201910.14
-16.61
2.17
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(4)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO |
| Networth | |||
| Borrowings | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Solvency + | |||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||
| Current Ratio | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO |
| Performance | |||
| Gross Margin | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO |
| Return + | |||
| Return on Equity | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||
| Days Payable | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO |
| Working Capital | |||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Madan Mohan Reddy Mettu | 01284266 | 5 years |
| Director | Sivakumaran Meenakshisunderam | 01284320 | 5 years |
| CEO | Satakarni Makkapati | <HIDDEN> | 3 years |
| Director | Mylandlahalli Rammohan Ashwini | 10568862 | 1 years |
| CS | Pravin Bhujanga Shettigar | <HIDDEN> | 3 years |
| Kmp | Ankur Pathak | <HIDDEN> | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| AUROBINDO PHARMA LTD |
Active
|
58.1 Cr | 1 | Telangana |
| OREMSI PLASTICS PRIVATE LIMITED |
Strike Off
|
1.3 L | 1 | Telangana |
| CUREPRO PARENTERALS LIMITED |
Amalgamated
|
13.3 Cr | 2 | Telangana |
| AURONEXT PHARMA PRIVATE LIMITED |
Amalgamated
|
125.0 Cr | 1 | Telangana |
| THERANYM BIOLOGICS PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
| AUROZEST PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
| AURO VACCINES PRIVATE LIMITED |
Active
|
10.0 L | 2 | Telangana |
| CREST EXCIPIENTS LLP |
Strike Off
|
1.3 L | 1 | Telangana |
| EUGIA STERILES PRIVATE LIMITED |
Active
|
44.2 Cr | 2 | Telangana |
| EUGIA PHARMA SPECIALITIES LIMITED |
Active
|
621.0 Cr | 1 | Telangana |
| PRAVESHA INDUSTRIES PRIVATE LIMITED |
Active
|
10.0 Cr | 1 | Telangana |
| EUGIA SEZ PRIVATE LIMITED |
Active
|
4.0 Cr | 2 | Telangana |
| TRIDENT LIFE SCIENCES LIMITED |
Amalgamated
|
1.6 L | 1 | Telangana |
| APL RESEARCH CENTRE LIMITED |
Amalgamated
|
12.3 Cr | 1 | Telangana |
| AUROZYMES LIMITED |
Amalgamated
|
5.0 L | 1 | Telangana |
| AUROACTIVE PHARMA PRIVATE LIMITED |
Active
|
100.0 Cr | 2 | Telangana |
| AURO PEPTIDES LIMITED |
Active
|
265.9 Cr | 1 | Telangana |
| TERGENE BIOTECH LIMITED |
Active
|
45.0 Cr | 1 | Telangana |
| AUROBINDO PHARMA FOUNDATION |
Active
|
1.0 L | 1 | Telangana |
| APL HEALTHCARE LIMITED |
Active
|
216.0 Cr | 2 | Telangana |
| APITORIA PHARMA PRIVATE LIMITED |
Active
|
99.0 Cr | 1 | Telangana |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| THERANYM BIOLOGICS PRIVATE LIMITED | Telangana | 2022 | ₹ 10.0 L |
The incorporation date of CURATEQ BIOLOGICS PRIVATE LIMITED is 25 April, 2020
The authorized share capital of CURATEQ BIOLOGICS PRIVATE LIMITED is INR ₹ 100.0 Cr.
The paid-up capital of CURATEQ BIOLOGICS PRIVATE LIMITED is INR ₹ 100.0 Cr.
The registered address of CURATEQ BIOLOGICS PRIVATE LIMITED is Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderaba d Knowledge City, Raidurg Panmak tha NA Hyderabad Rangareddi Telangana - 500032
The CIN number of CURATEQ BIOLOGICS PRIVATE LIMITED is U24110TG2020PTC140190.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
